188 related articles for article (PubMed ID: 25511546)
1. A new tumor biomarker, serum protein peak at 3,144 m/z, in patients with node-positive breast cancer.
Chen Z; Xu S; Su D; Liu W; Yang H; Xie S; Meng X; Lei L; Wang X
Clin Transl Oncol; 2015 Jun; 17(6):486-94. PubMed ID: 25511546
[TBL] [Abstract][Full Text] [Related]
2. Serum biomarker 3144 m/z for prognostic detection in Chinese postmenopausal breast cancer patients.
Gao Y; Xu S; Cao W; Chen Z; Wang X; Zou D
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C68-73. PubMed ID: 26323928
[TBL] [Abstract][Full Text] [Related]
3. Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.
Shao Y; Sun X; He Y; Liu C; Liu H
PLoS One; 2015; 10(7):e0133830. PubMed ID: 26207909
[TBL] [Abstract][Full Text] [Related]
4. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
[TBL] [Abstract][Full Text] [Related]
7. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer.
Nisman B; Maimon O; Allweis T; Kadouri L; Maly B; Hamburger T; Peretz T
Anticancer Res; 2013 Jan; 33(1):293-9. PubMed ID: 23267160
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.
Samy N; Ragab HM; El Maksoud NA; Shaalan M
Cancer Biomark; 2010; 6(2):63-72. PubMed ID: 20571232
[TBL] [Abstract][Full Text] [Related]
10. Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer?
Velaiutham S; Taib NA; Ng KL; Yoong BK; Yip CH
Asian Pac J Cancer Prev; 2008; 9(3):445-8. PubMed ID: 18990019
[TBL] [Abstract][Full Text] [Related]
11. [Expression of a protein peak(3144 m/z) in serum and its clinical significance in patients with gastric cancer].
Xu SH; Su D; Zhu X; Zheng ZG; Xu Q; Zhu CH; Xie JB; Yu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):165-8. PubMed ID: 22368026
[TBL] [Abstract][Full Text] [Related]
12. Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.
Jiang X; Guo D; Li W; Yu T; Zhou J; Gong J
Mol Med Rep; 2017 Mar; 15(3):1123-1134. PubMed ID: 28112378
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study.
Li J; Liu L; Feng Z; Wang X; Huang Y; Dai H; Zhang L; Song F; Wang D; Zhang P; Ma B; Li H; Zheng H; Song F; Chen K
Breast Cancer; 2020 Jul; 27(4):621-630. PubMed ID: 32040723
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of CA15.3 in 7942 patients with operable breast cancer.
Sandri MT; Salvatici M; Botteri E; Passerini R; Zorzino L; Rotmensz N; Luini A; Mauro C; Bagnardi V; Cassatella MC; Bottari F; Casadio C; Colleoni M
Breast Cancer Res Treat; 2012 Feb; 132(1):317-26. PubMed ID: 22065291
[TBL] [Abstract][Full Text] [Related]
16. Primary study of lymph node metastasis-related serum biomarkers in breast cancer.
Wang L; Su D; Yan HJ; Xu JH; Zheng ZG; Hu YJ; Pan XD; Ding XW; Chen C; Chen B; Mao WM; Meng XL
Anat Rec (Hoboken); 2011 Nov; 294(11):1818-24. PubMed ID: 21964916
[TBL] [Abstract][Full Text] [Related]
17. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
18. Use of CA15-3, CEA and prolactin for the primary diagnosis of breast cancer and correlation with the prognostic factors at the time of initial diagnosis.
Arslan N; Serdar M; Deveci S; Ozturk B; Narin Y; Ilgan S; Ozturk E; Ozguven MA
Ann Nucl Med; 2000 Oct; 14(5):395-9. PubMed ID: 11108173
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of CEA and CA15-3 in different molecular subtypes and prognostic value in Chinese breast cancer.
Wu SG; He ZY; Zhou J; Sun JY; Li FY; Lin Q; Guo L; Lin HX
Breast; 2014 Feb; 23(1):88-93. PubMed ID: 24291374
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of miR-195 with invasiveness and prognosis of breast cancer].
Song CG; Wu XY; Wang C; Fu FM; Shao ZM
Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
